NASDAQ:PRPO

Precipio (PRPO) Stock Forecast, Price & News

$5.74

+0.13 (+2.32%)

(As of 10/2/2023 ET)

Compare

Today's Range: $5.61
▼
$5.87
50-Day Range: $5.30
▼
$112.00
52-Week Range: $4.75
▼
$20.48

Volume: 4,823 shs
Average Volume: 26,557 shs
Market Capitalization: $7.92 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $40.00

Precipio MarketRank™ Forecast

Analyst Rating: 0.00 Rating Score
Upside/Downside: 596.9% Upside
$40.00 Price Target
Short Interest: Healthy
1.07% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.07
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.64 out of 5 stars

2.0

Analyst's Opinion

Price Target Upside/Downside
According to analysts' consensus price target of $40.00, Precipio has a forecasted upside of 596.9% from its current price of $5.74.
Amount of Analyst Coverage
Precipio has received no research coverage in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
1.07% of the float of Precipio has been sold short.
Short Interest Ratio / Days to Cover
Precipio has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Precipio has recently decreased by 92.54%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Precipio does not currently pay a dividend.
Dividend Growth
Precipio does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for PRPO.

1.7

News and Social Media Coverage

News Sentiment
Precipio has a news sentiment score of 0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.70 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Precipio this week, compared to 0 articles on an average week.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Precipio insiders have not sold or bought any company stock.
Percentage Held by Insiders
10.60% of the stock of Precipio is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 16.43% of the stock of Precipio is held by institutions.

0.6

Earnings and Valuation

Price to Book Value per Share Ratio
Precipio has a P/B Ratio of 0.40. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Precipio (NASDAQ:PRPO) Stock

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests. It sells ICE- technology kits to bio-pharma customers. The company is based in New Haven, Connecticut.

PRPO Price History

30 days | 90 days | 365 days | Advanced Chart

PRPO Stock News Headlines

September 29, 2023 | americanbankingnews.com

Precipio (NASDAQ:PRPO) Shares Pass Below 200 Day Moving Average of $10.19

September 28, 2023 | finance.yahoo.com

Precipio Continues to Sign New HemeScreen™ Customers

October 3, 2023 | Edge On The Street (Ad)

Is Gold Really Boring?

Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.

September 25, 2023 | finance.yahoo.com

Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven

September 22, 2023 | finanznachrichten.de

Precipio, Inc.: Precipio Takes Final Step Towards Regaining Nasdaq Compliance

September 13, 2023 | finance.yahoo.com

Precipio’s Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan

August 20, 2023 | finance.yahoo.com

Broker Revenue Forecasts For Precipio, Inc. (NASDAQ:PRPO) Are Surging Higher

August 19, 2023 | finance.yahoo.com

Precipio, Inc. (NASDAQ:PRPO) Q2 2023 Earnings Call Transcript

October 3, 2023 | Wall Street Fundamentals (Ad)

The "Plug and Play" Model Putting Online Giants to Shame

While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."

August 16, 2023 | benzinga.com

Precipio's Earnings: A Preview

August 13, 2023 | finance.yahoo.com

Precipio, Inc.'s (NASDAQ:PRPO) Shares Not Telling The Full Story

August 11, 2023 | finance.yahoo.com

Precipio Announces Q2-2023 Shareholder Update Call

August 8, 2023 | finance.yahoo.com

Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel

August 3, 2023 | finance.yahoo.com

Precipio’s Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven

August 1, 2023 | investing.com

End in sight for U.S. insider trading case over healthcare leaks

August 1, 2023 | finance.yahoo.com

Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023

July 6, 2023 | msn.com

Precipio (PRPO) Price Target Decreased by 29.82% to 2.04

June 13, 2023 | finance.yahoo.com

Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technology

June 8, 2023 | msn.com

Why Oxford Industries Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

June 8, 2023 | marketwatch.com

Precipio Shares Slide Premarket on Sale of Equities >PRPO

June 8, 2023 | finance.yahoo.com

Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

June 7, 2023 | finance.yahoo.com

Projected cash burn reduced by $1.5 million annually from Three Operational Efficiency Projects

May 17, 2023 | msn.com

Precipio GAAP EPS of -$0.13 misses by $0.02, revenue of $2.82M beats by $0.02M

May 17, 2023 | finance.yahoo.com

Precipio Shares Growth Catalysts For HemeScreen

May 15, 2023 | finance.yahoo.com

Precipio Announces Q1-2023 Shareholder Update Call

May 4, 2023 | finance.yahoo.com

Precipio Signs Another HemeScreen™ Customer

May 4, 2023 | finance.yahoo.com

Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division

See More Headlines

Receive PRPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter.

PRPO Company Calendar

Last Earnings: 8/11/2023
Today: 10/03/2023
Next Earnings (Estimated): 11/09/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Analytical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:PRPO
CUSIP: N/A
CIK: 1043961
Web: www.precipiodx.com
Phone: (203) 787-7888
Fax: 402-452-5401
Employees: 53
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $40.00
High Stock Price Forecast: $40.00
Low Stock Price Forecast: $40.00
Forecasted Upside/Downside: +596.9%
Consensus Rating
Rating Score (0-4): 0.00
Research Coverage: 0 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-12,200,000.00
Net Margins: -98.50%
Pretax Margin: -98.38%
Return on Equity: -68.54%
Return on Assets: -51.39%

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 0.92
Quick Ratio: 0.81

Sales & Book Value

Annual Sales: $9.41 million
Price / Sales: 0.84
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $14.34 per share
Price / Book: 0.40

Miscellaneous

Outstanding Shares: 1,380,000
Free Float: 1,232,000
Market Cap: $7.92 million
Optionable: Not Optionable
Beta: 2.04

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Mr. Ilan Danieli (Age 51)
Founder, Pres, CEO & Director
Comp: $324.1k

Dr. Ayman A. Mohamed M.D. (Age 38)
Chief Technology Officer
Comp: $234.1k

Mr. Matthew Gage (Age 56)
Interim Chief Financial Officer

Mr. Ahmed Zaki Sabet (Age 36)
Chief Operating Officer

Ms. Miri Chiko-Radomski
Chief Legal Counsel & People Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

PRPO Stock - Frequently Asked Questions

What is Precipio's stock price forecast for 2023?: 0 brokers have issued 1 year price objectives for Precipio's shares. Their PRPO share price forecasts range from $40.00 to $40.00. On average, they anticipate the company's stock price to reach $40.00 in the next year. This suggests a possible upside of 596.9% from the stock's current price.
View analysts price targets for PRPO or view top-rated stocks among Wall Street analysts.
How have PRPO shares performed in 2023?: Precipio's stock was trading at $11.0280 at the beginning of the year. Since then, PRPO shares have decreased by 48.0% and is now trading at $5.74.
View the best growth stocks for 2023 here.
When is Precipio's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our PRPO earnings forecast.
How were Precipio's earnings last quarter?: Precipio, Inc. (NASDAQ:PRPO) announced its quarterly earnings data on Friday, August, 11th. The biotechnology company reported ($1.80) EPS for the quarter. The biotechnology company had revenue of $3.53 million for the quarter. Precipio had a negative trailing twelve-month return on equity of 68.54% and a negative net margin of 98.50%.
When did Precipio's stock split?: Shares of Precipio reverse split on Friday, September 22nd 2023. The 1-20 reverse split was announced on Friday, September 22nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, September 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Precipio own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Precipio investors own include Biocept (BIOC), Heat Biologics (HTBX), Portola Pharmaceuticals (PTLA), iBio (IBIO), Inovio Pharmaceuticals (INO), T2 Biosystems (TTOO), VBI Vaccines (VBIV), Co-Diagnostics (CODX), Inpixon (INPX) and Jaguar Health (JAGX).
What is Precipio's stock symbol?: Precipio trades on the NASDAQ under the ticker symbol "PRPO."
How do I buy shares of Precipio?: Shares of PRPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Precipio's stock price today?: One share of PRPO stock can currently be purchased for approximately $5.74.
How much money does Precipio make?: Precipio (NASDAQ:PRPO) has a market capitalization of $7.92 million and generates $9.41 million in revenue each year.
How can I contact Precipio?: Precipio's mailing address is 4 Science Park, New Haven CT, 06511. The official website for the company is www.precipiodx.com. The biotechnology company can be reached via phone at (203) 787-7888, via email at investors@precipiodx.com, or via fax at 402-452-5401.

This page (NASDAQ:PRPO) was last updated on 10/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial